Michael William Kavanaugh

Cso, Head Res.&Non-Clin. Dev. at Cytomx Therapeutics Inc. (CTMX), 2020-02-19
Svp & Chief Scientific Officer at Five Prime Therapeutics Inc (FPRX), 2014-08-26

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
CTMX	$12.00	5,000	$60,000.00	5,000	2015-10-14	Filing

Insider Trading: Sales See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
CTMX	$24.34	48,368	$1,177,277.12	13,917	2017-10-04	Filing